Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20151839 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine
Condition: HIV-1
Interventions: Drug: Maraviroc + Zidovudine/Lamivudine;   Drug: Efavirenz + Zidovudine/Lamivudine;   Drug: Maraviroc (UK-427,857) + Zidovudine/Lamivudine

Indicates status has not been verified in more than two years